New platform integrates microfluidics and metasurface for kidney disease testing

New platform integrates microfluidics and metasurface for kidney disease testing

Development of a new way to accurately measure human serum albumin (HSA) levels in people with chronic kidney disease has progressed in recent testing by Flinders University and Japanese researchers. Development of a new way to accurately measure human serum albumin (HSA) levels in people with chronic kidney disease has progressed in recent testing by Flinders University and Japanese researchers. Bio & Medicine Nanomaterials Phys.org – latest science and technology news stories

Leave a Reply

Your email address will not be published. Required fields are marked *